Mrna Covid-19 Vaccines Could 'turbo-Charge' Cancer Treatments

Relatedly, the shingles vaccine seems to delay or reduce Alzheimer's onset

https://www.nature.com/articles/s41591-024-03201-5

> We show that the recombinant vaccine is associated with a significantly lower risk of dementia in the 6 years post-vaccination. Specifically, receiving the recombinant vaccine is associated with a 17% increase in diagnosis-free time, translating into 164 additional days lived without a diagnosis of dementia in those subsequently affected. The recombinant shingles vaccine was also associated with lower risks of dementia than were two other vaccines commonly used in older people: influenza and tetanus–diphtheria–pertussis vaccines. The effect was robust across multiple secondary analyses, and was present in both men and women but was greater in women.